Back to company

SCANPHARM A/S: Financial statements 2015

CVR: 16279099

SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 20,446,816 and a net result of DKK 715,522 compared with DKK 431,209 the year before. That is a decrease of 1.6% compared with the year before. Equity amounted to DKK 11,704,517. The solvency ratio was 37.6%. The company had 42 employees in the financial year.

Gross Profit
20,446,816 kr.
Profit/Loss
715,522 kr.
Equity
11,704,517 kr.
Total Assets
31,126,089 kr.
Employees
42

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-20.4 mio.716 t.11.7 mio.42
2014-20.8 mio.431 t.11 mio.-
2013-20.9 mio.400 t.10.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2015

SCANPHARM A/S: The 2014 annual report is outJun 1, 2015

SCANPHARM A/S has published its annual report for 2014. Gross profit came to DKK 20,769,828, and the net result was DKK 431,209.

About SCANPHARM A/S

SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees. In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity amounted to DKK 3,045,406.